Using Public Data for Cancer Prevention and Control: From Innovation to Impact

Challenge Background

The National Cancer Institute (NCI), Division of Cancer Control and Population Sciences (DCCPS) is announcing the launch of the Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge. This Challenge is sponsored by the NCI and is presented as part of the Office of the National Coordinator for Health Information Technology’s Investing in Innovation (i2) program. This contest addresses the NCI DCCPS mission to disseminate information towards the prevention, early detection, diagnosis, treatment, and control of cancer.

Challenge Description

Entrants are asked to develop innovative software applications (apps) that address challenges faced by consumers, clinicians, or researchers at one or more points on the cancer control continuum. These apps should also use public data that are relevant to cancer prevention and control, and have the potential to integrate with existing technology platforms. Suggested targets include promoting healthy behaviors (e.g., nutrition, physical activity, smoking cessation,…), early detection and screening, informed decision-making, and adherence to treatment plans. The diagram below also illustrates where the gaps exist in the handoff of data and information.

Registration is free and can be completed anytime during the Phase I App Submission Period, July 21 to August 26, 2011.

Additional Information:
NCI, part of the National Institutes of Health (NIH), was established by Congress in 1937 and is the leading Federal agency and the world’s largest organization solely dedicated to cancer-related research (including health communication and informatics), training, and dissemination of information. For more information, see www.cancer.gov.

Winners and finalists who meet the requisite qualifications, along with all interested and qualified parties, are also encouraged to apply for relevant funding opportunities to further develop and commercialize their innovative apps for cancer prevention and control, e.g., in NCI’s Small Business Innovation Research (SBIR) program: http://sbir.cancer.gov/.

Evaluation Criteria

Phase I and Phase II entries will be evaluated by an expert panel composed of NCI program staff and external members of the health information technology community in compliance with the requirements of the America COMPETES Act. Advisors may be named after commencement of the challenge. The review panel will make selections based upon the following criteria:

  1. Use of cancer-related data: Each entry must use at least one dataset or data service relevant to cancer prevention and control, as described in the section on evaluation criterion #2. When appropriate to the app, the use of additional datasets from other sources is also encouraged.
  2. Impact on the continuum of cancer prevention and control: Each entry will be rated on the strength of its potential to help consumers, clinicians, and/or researchers address challenges related to the continuum of cancer prevention and control.  Suggested targets comprise behavior risk reduction for prevention/survivorship (e.g., nutrition, physical activity, smoking cessation), early detection and screening, informed decision-making, and adherence to treatment regimens.  Examples include, but are not limited to, apps that provide new ways of visualizing and communicating complex health information for risk communication; consumer decision support incorporating multiple sources of data to reduce the burden of cancer and enhance outcomes following diagnosis and treatment; and decision aides for cancer screening (e.g., prostate-specific antigen (PSA), breast, and cervical cancer screening tests).  A detailed framework describing the continuum and related resources is available at the NCI DCCPS website: http://cancercontrol.cancer.gov/od/continuum.html. Also see:
    • Zapka JG, Taplin SH, Solberg LI, Manos MM. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev. 2003 Jan; 12(1):4-13).
    • Taplin SH, Clauser S, Rodgers AB, Breslau E, Rayson D. Interfaces across the cancer continuum offer opportunities to improve the process of care. J Natl Cancer Inst Monogr 2010;2010(40):104-10.
    • Hesse BW, Hanna C, Massett HA, Hesse NK. Outside the box: will information technology be a viable intervention to improve the quality of cancer care? J Natl Cancer Inst Monogr 2010;2010(40):81-9.
  3. Integration: Each entry will be rated on its potential for, or actual integration with existing electronic health record (EHR; recommended standards can be found here), personal health record (PHR), mobile, Web, and/or other emerging health information technology platforms.
  4. Innovation: Each entry will be rated for the degree of new thinking it brings to applications targeting the continuum of cancer prevention and control, and the creativity shown in designing for impact.
  5. Usability: Each entry will be rated on its user-friendliness and interactive capabilities. Preference will be given to applications that are easily accessible to a range of users, including those with disabilities.

Submissions should include a title, textual description of the submission, a link to the app, and a list of data sources and/or datasets used. Pictures and video are optional but helpful.

Timeline

  • Phase I Submission Deadline - August 26, 2011 (11:59 pm EST)
  • Phase II Submission Deadline - November 18, 2011 (11:59pm EST)

Terms & Conditions

Expand